NCT07503847

Brief Summary

The primary objective of this study was to evaluate the impact of a constructed shared decision (SDM) intervention (offering an option between colonoscopy and immunochemical collapsible occult blood testing (fecal immunochemical test; FIT)) on improving the incidence of high colonoscopy stromal in patients aged 40-49 years with a close relative suffering from colorectal cancer, compared to standard care (direct referral for colonoscopy).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,286

participants targeted

Target at P75+ for not_applicable colorectal-cancer

Timeline
5mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Sep 2025Dec 2026

Study Start

First participant enrolled

September 1, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 10, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 31, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 31, 2026

Status Verified

November 1, 2025

Enrollment Period

1.3 years

First QC Date

March 10, 2026

Last Update Submit

March 26, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Colonoscopy screening rate

    Completion of colonoscopy within 3 months after randomization, defined as documented completion of colonoscopy or colonoscopy performed after a positive FIT result.

    Within 3 months after randomization

Secondary Outcomes (3)

  • Patient satisfaction with shared decision-making

    Immediately after the SDM consultation visit

  • Participant choice of screening modality (colonoscopy vs fecal immunochemical test)

    Immediately after the intervention

  • Detection rate of colorectal neoplasia

    During colonoscopy procedure

Study Arms (2)

Shared Decision-Making

EXPERIMENTAL

Shared Decision-Making

Behavioral: Shared Decision-Making

Colonoscopy

ACTIVE COMPARATOR

Colonoscopy

Diagnostic Test: Colonoscopy

Interventions

ColonoscopyDIAGNOSTIC_TEST

Participants underwent standard colonoscopy performed by experienced endoscopists following routine clinical procedures.

Colonoscopy

Participants received a shared decision-making intervention including educational materials and discussion with clinicians to choose between screening options.

Shared Decision-Making

Eligibility Criteria

Age40 Years - 49 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 40 to 49 years at the time of recruitment.
  • At least one immediate family member (biological parent, sibling, or child) has been pathologically diagnosed with colorectal cancer.
  • Able to read, understand, and provide prior consent.
  • Willing to be randomly assigned to any research group and complete all research procedures.

You may not qualify if:

  • A personal history of colorectal cancer or inflammatory bowel disease (Crohn's disease or ulcerative colitis).
  • Presence of warning signs of colorectal cancer requiring diagnostic evaluation rather than screening (e.g., unexplained rectal bleeding, significant involuntary weight loss, persistent changes in bowel habits).
  • Presence of comorbidities that may contraindicate colonoscopy.
  • Having undergone colonoscopy within the past three years.
  • Inability to read, understand, and provide written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

MeSH Terms

Conditions

Colonic Neoplasms

Interventions

Colonoscopy

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 10, 2026

First Posted

March 31, 2026

Study Start

September 1, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 31, 2026

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

Locations